Raymond James Financial’s Vigil Neuroscience VIGL Stock Holding History

Raymond James Financial’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-501	Closed	-$3.98K	–	6726
2025 Q2	$3.98K	Buy	+501	New	+$2.25K	﹤0.01%	6237

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Raymond James Financial's VIGL Position: Q3 2025 in Review

Raymond James Financial sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 501 shares — an estimated $3.98K sold.

Raymond James Financial first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $3.98K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Raymond James Financial reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 501 Vigil Neuroscience shares in Q3 2025, an estimated $3.98K.
Raymond James Financial first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Raymond James Financial's Vigil Neuroscience position peaked at $3.98K in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.